Showing results (121-130 of 269) with videos related to
Sort By:
Pageof 27
Blood|November 1, 1978
Acute lymphoblastic leukemia followed by chronic myelocytic leukemiaG Tosato, J Whang-Peng, A S Levine, et al.Blood|April 18, 1998
Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivoB W Cherney, C Sgadari, C Kanegane, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1981
Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin productionT A Fleisher, W C Greene, R M Blaese, et al.Cancer Research|April 1, 1976
The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosisD G Poplack, N A Sher, S D Chaparas, et al.Human Gene Therapy|May 20, 1997
Keratinocyte gene therapy for adenosine deaminase deficiency: a model approach for inherited metabolic disordersE S Fenjves, P M Schwartz, R M Blaese, et al.Human Gene Therapy|June 20, 1996
High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectorsT Leimig, M Brenner, J Ramsey, et al.Cellular Immunology|December 1, 1994
Characterization of T cell ligands for uromodulin: a possible role in costimulationB B Mishra, A M Fernandes, R M Blaese, et al.The Journal of Clinical Investigation|October 1, 1978
Immunoglobulin secreting cells in normal human bronchial lavage fluidsE C Lawrence, R M Blaese, R R Martin, et al.Acta Haematologica|April 15, 1999
Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trialsM Onodera, D M Nelson, Y Sakiyama, et al.Gene Therapy|February 19, 1999
The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communicationR L Touraine, H Ishii-Morita, W J Ramsey, et al.Pageof 27